Kwok C F, Chen M L, Shih K C, Hwu C M, Ho L T
Department of Medicine, Taipei Veterans General Hospital, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi (Taipei). 2001 Aug;64(8):427-32.
Prostacyclin (PGI2) is a potent vasodilator and inhibitor of platelet aggregation. It may reduce in diabetic patients to contribute to the platelet hyperaggregability and acceleration of atherosclerosis. While the major clinical manifestation of diabetes mellitus is increased blood levels of glucose, elevation of free fatty acids (FFA) levels in the circulation has also been reported.
Cultured rat aortic endothelial cells were treated with media containing high concentration of FFA (oleic acid 0.5 mM, palmitic acid 0.25 mM, linoleic acid 0.25 mM, stearic acid 0.06 mM, arachidonic acid 0.04 mM, total 1.1 mM, and the molar ratio of FFA/albumin < 2), glucose (22 mM) or both. Then the PGI2 release was studied by measuring 6-keto-PGF1alpha in the media.
We found that high concentration of FFA increased the PGI2 production at basal (1.227 +/- 0.031 vs 0.762 +/- 0.028 ng/mg protein, n = 6, p = 0.002) and when stimulated by 0.5 unit/ml of thrombin (2.708 +/- 0.115 vs 1.337 +/- 0.225 ng/mg protein, n = 6, p = 0.002). Two-day treatment with high-glucose did not affect PGI2 production. However, in the presence of high-glucose, the enhancement by high FFA of thrombin stimulated PGI2 production disappeared (high-glucose 1.461 +/- 0.312 ng/mg, normal-glucose 2.708 +/- 0.115 ng/mg, n = 6, p = 0.002).
The interaction between glucose and FFA can reduce PGI2 production in thrombin-stimulated state. Our findings further support their role in the pathogenesis of platelet hyperaggregability and acceleration of atherosclerosis in diabetes.
前列环素(PGI2)是一种强效血管舒张剂和血小板聚集抑制剂。在糖尿病患者中其水平可能降低,这有助于血小板高聚集性和动脉粥样硬化的加速发展。虽然糖尿病的主要临床表现是血糖水平升高,但也有报道称循环中游离脂肪酸(FFA)水平会升高。
用含有高浓度FFA(油酸0.5 mM、棕榈酸0.25 mM、亚油酸0.25 mM、硬脂酸0.06 mM、花生四烯酸0.04 mM,总量1.1 mM,且FFA/白蛋白摩尔比<2)、葡萄糖(22 mM)或两者的培养基处理培养的大鼠主动脉内皮细胞。然后通过测量培养基中的6-酮-PGF1α来研究PGI2释放。
我们发现,高浓度FFA在基础状态下增加了PGI2的产生(1.227±0.031对0.762±0.028 ng/mg蛋白,n = 6,p = 0.002),并且在受到0.5单位/ml凝血酶刺激时也增加了PGI2的产生(2.708±0.115对1.337±0.225 ng/mg蛋白,n = 6,p = 0.002)。高糖处理两天不影响PGI2的产生。然而,在高糖存在的情况下,高FFA对凝血酶刺激的PGI2产生的增强作用消失了(高糖1.461±0.312 ng/mg,正常糖2.708±0.115 ng/mg,n = 6,p = 0.002)。
葡萄糖和FFA之间的相互作用可降低凝血酶刺激状态下PGI2的产生。我们的研究结果进一步支持了它们在糖尿病患者血小板高聚集性和动脉粥样硬化加速发展的发病机制中的作用。